Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SURESH G NAIR

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1669423711
CMS profile
166428
Location
ALLENTOWN, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$149.49

2 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $149.49 2

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Astellas Pharma US Inc $124.74 1
E.R. Squibb & Sons, L.L.C. $24.75 1

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SURESH G NAIR

NPI 1669423711 · CMS profile ID 166428

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

ALLENTOWN, PA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1669423711?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SURESH G NAIR, NPI 1669423711, CMS profile ID 166428. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1669423711?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). SURESH G NAIR, NPI 1669423711, CMS profile ID 166428. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1669423711?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
SURESH G NAIR, NPI 1669423711, CMS profile ID 166428, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1669423711?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

2 matching records · $149.49 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 2 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–2 of 2.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $24.7509/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101786114 CMS
Astellas Pharma US Inc $124.7403/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139379724 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $125.76 9
PY2020 $69.07 4
PY2021 $61.31 4
PY2022 $80.04 1
PY2023 $78.24 1
PY2024 $149.49 2
PY2025 $295.85 4

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $194,965.34 40
PY2024 Principal investigator $148,310.84 44
PY2023 Principal investigator $382,804.46 29
PY2022 Principal investigator $135,383.95 27
PY2021 Principal investigator $617,414.43 31
PY2020 Principal investigator $541,006.34 33
PY2019 Principal investigator $398,239.66 27

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

27 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $2,511.20 12/04/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase III Adjuvant Melanoma Stage II B C Opdivo Mono No dispute reported 06/30/2026 708963705
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,500.00 11/20/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Ph IIB NSCLC 3L squamous refractory No dispute reported 06/30/2026 639756479
Principal investigator 1 AbbVie, Inc. $1,500.00 09/24/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
M14-011 No dispute reported 06/30/2026 647574559
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $385.64 09/24/2019 Non-covered Recipient Entity
Lehigh Valley Hospital
Ph II III IO Naive Mel lag3 nivo No dispute reported 06/30/2026 639756475
Principal investigator 1 Merck Sharp & Dohme Corporation $1,500.00 09/19/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
A Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab MK-3475 in Combination with Axitinib versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma mRCC KEYNOTE-426 No dispute reported 06/30/2026 691350877
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,500.00 08/30/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase III MEL 1L, PD-1 vs Ipi vs. PD-1 Ipi No dispute reported 06/30/2026 639756503
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $5,167.50 08/23/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase III Adjuvant Melanoma Monotherapy No dispute reported 06/30/2026 639756499
Principal investigator 1 AbbVie, Inc. $500.00 08/21/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
M14-011 No dispute reported 06/30/2026 647574557
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,094.00 08/19/2019 Non-covered Recipient Entity
Lehigh Valley Health Network - Parent Account
Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma CheckMate 067 No dispute reported 06/30/2026 639756481
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $671.71 08/19/2019 Non-covered Recipient Entity
Ohio State University Research Foundation
Phase III NSCLC 1L combo No dispute reported 06/30/2026 639756507
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $3,000.00 08/08/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
A Multi-center Phase II Blinded or Open-Label Study to Evaluate Tumor Response in Subjects with Melanoma Brain Metastases Treated with Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab No dispute reported 06/30/2026 639756469
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $2,010.30 07/05/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase III NSCLC 1L combo No dispute reported 06/30/2026 639756505
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,940.10 07/05/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase III RCC 1L Combo No dispute reported 06/30/2026 639756511
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $11,724.40 05/28/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase IIB Hodgkins Lymphoma No dispute reported 06/30/2026 708963707
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $29,884.50 04/29/2019 Non-covered Recipient Entity
Memorial Sloan Kettering Cancer Center
Phase III 1L Metastatic RCC Nivo Ipi Cabo No dispute reported 06/30/2026 708963833
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,713.30 04/03/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase III 1L GBM Unmethylated MGMT nivo mono RT No dispute reported 06/30/2026 639756491
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $2,000.00 03/26/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Ph I II mono lag3 vs combo lag3 nivo solid tumors No dispute reported 06/30/2026 639756473
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $2,655.00 03/18/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase IIIB Dose Comparison N3 I1 vs I3 N1 in melanoma No dispute reported 06/30/2026 639756513
Principal investigator 1 AbbVie, Inc. $500.00 03/13/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
M14-011 No dispute reported 06/30/2026 647574555
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $4,907.50 02/14/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Ph II III IO Naive Mel lag3 nivo FDC No dispute reported 06/30/2026 639756477
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $55,796.30 02/07/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase III 1L GBM Methylated nivo mono chemo RT No dispute reported 06/30/2026 639756489
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $3,148.50 02/04/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase III Adjuvant Bladder nivo mono No dispute reported 06/30/2026 639756497
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $2,364.00 01/28/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase II Sequential Ipi - Anti-PD-1 No dispute reported 06/30/2026 639756483
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $14,049.14 01/10/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase III NSCLC 1L, sq anti-PD-1 vs platinum doublet PDL-1 No dispute reported 06/30/2026 639756509
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $2,128.07 01/04/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase III Adjuvant Bladder nivo mono No dispute reported 06/30/2026 639756495
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $236,438.50 01/03/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma FRACTION-RCC No dispute reported 06/30/2026 639756471
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $7,650.00 01/02/2019 Covered Recipient Teaching Hospital
LEHIGH VALLEY
Phase IIB Hodgkins Lymphoma No dispute reported 06/30/2026 639756487